I-Factor Peptide Enhanced Bone Graft
Device Peptide Enhanced Bone Graft
PDI 00850001680004
General payments
$3,718,811
Research payments
$799,837
Through program year 2025, $3,718,811 in general payments and $799,837 in research payments were reported against I-Factor Peptide Enhanced Bone Graft (Peptide Enhanced Bone Graft).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $796,323 | 1,898 |
| 2025 | Research | $507,413 | 101 |
| 2024 | General | $796,362 | 2,115 |
| 2024 | Research | $292,424 | 71 |
| 2023 | General | $673,059 | 1,742 |
| 2022 | General | $988,561 | 1,923 |
| 2021 | General | $464,507 | 1,752 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 43 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 48 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
9,430 general · 172 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.